UNSPSC 51283946: Sulfamonomethoxine

This classification denotes a sulfonamide anti-infective agent with the molecular formula C11H12N4O3S, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier U700P169W2, chemically known as sulfanilamide, n(sup 1)-(6-methoxy-4-pyrimidinyl)- but more generally known as sulfamonomethoxine, which bears U.S. National Institutes of Health Compound Identifier 5332. The European Medicines Agency schedules Sulfamonomethoxine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10716MIG.

UNSPSC 51283946 Sulfamonomethoxine is a Commodity code that in practice covers pharmaceutical procurement by state and local governments, though recent opportunities show limited direct activity under this specific code. The source reflects state and local buying of generic pharmaceuticals, naloxone, medical supplies, and over-the-counter products through both direct purchase and cooperative purchasing mechanisms, with issuing bodies spanning state health agencies, county health departments, municipal fire departments, and multistate cooperative purchasing alliances. Scope of work includes procurement of finished pharmaceutical products—generic drugs, naloxone kits, medical and first aid supplies for emergency response—with vendors typically required to supply through authorized wholesalers or deliver directly to specified government facilities. Issuing bodies include the Minnesota Department of Administration (administering MMCAP), Texas Health and Human Services Commission, Seminole County Florida, and the City of Tampa, reflecting a mix of state-level procurement offices, county health entities, and municipal departments.

Recent activity clusters in three states: Minnesota (through MMCAP's multistate cooperative vehicle), Texas (through the state HHS Commission's direct-to-manufacturer pharmacy initiative), and Florida (through Seminole County). The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP for generic multi-source pharmaceuticals and OTC products with proposals due March 26, 2026, requiring vendors to supply through three authorized wholesalers and certify compliance with cGMP and DSCSA. Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2026, with quarterly deliveries to the Seminole County Community Health Building. The City of Tampa's Purchasing Department solicited sealed bids for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division (Bid 26-P-00145) with a $700,000 estimated contract amount and a designated small local business enterprise set-aside. The Texas HHS Commission issued an RFI (HHS0017013) in April 2026 to gather vendor capabilities for a direct-to-manufacturer prescription program, signaling exploratory procurement strategy development rather than immediate award activity.